The Role of Surgi-ORC® in Bleeding Control During Laparoscopic Cholecystectomy

The Role of Surgi-ORC® in Bleeding Control During Laparoscopic Cholecystectomy

 Laparoscopic cholecystectomy (LC) is a minimally invasive procedure for gallbladder removal in gallstone disease (cholelithiasis) and related complications. Compared with open surgery, LC offers less postoperative pain, shorter hospital stays, faster recovery, and better cosmetic outcomes.1,2

Press enter or click to view image in full size
Fig. 1: Laparoscopic cholecystectomy2

What clinical conditions commonly require LC?

LC is indicated in a wide range of gallbladder conditions, including3

  • Cholelithiasis
  • Mucocele or empyema of the gallbladder
  • Cholesterolosis
  • Typhoid carrier
  • Porcelain gallbladder
  • Acute cholecystitis (calculous and acalculous)
  • Adenomatous gallbladder polyps
  • As part of other procedures, viz., whipple’s procedure

Although LC generally provide better outcomes across these indications, effective haemostasis remains essential for procedural safety, as bleeding continues to be the most serious non-biliary complication.4

Why bleeding control is critical during LC?

Press enter or click to view image in full size

If not promptly managed, bleeding is a leading cause of procedure-related mortality. 4While electrocautery is the conventional tool for bleeding control, its thermal nature carries risks (damage to parenchymal tissue and postoperative bile leakage);1 hence, topical oxidized regenerated cellulose (ORC) agents such as Surgi-ORC®, can be used to achieve haemostasis and reduce these complications.

What is Surgi-ORC®?


Surgi-ORC® is a plant-based, absorbable haemostatic made of oxidized regenerated cellulose designed to control bleeding. ORC adheres easily to bleeding surfaces and is suitable for use in laparoscopic cholecystectomy.1 Surgi-ORC® is available in four variants: Surgi-ORC® ORIGINAL, Surgi-ORC® FIBRIL, Surgi-ORC® NON-WOVEN and Surgi-ORC® KNIT, haemostats.

Press enter or click to view image in full size
Fig.2: Surgi-ORC®: FIBRIL, KNIT, ORIGINAL, and NON-WOVEN haemostats.

How Does Surgi-ORC® Work to stop bleeding?

Surgi-ORC® is an absorbable topical haemostatic designed for rapid, localized control of bleeding from capillary, venous, and small arteriolar vessels. It works by:

  • ORC absorbs blood and forms a gel that covers the site of vessel injury
  • Creates a low-pH environment, leading to localized vasoconstriction
  • Acts as a matrix for platelet adhesion, accelerating clot formation

What advantages does Surgi-ORC® offer in LC?

Press enter or click to view image in full size

Together, these benefits make Surgi-ORC® particularly valuable in complex and high-risk cases.

Clinical Evidence: Efficacy of ORC in LC

A study conducted between January 2012 and August 2015 included 525 patients with acute cholecystitis undergoing fundus-first LC. Patients were classified by dissection difficulty: Group A (n=142) had an easily achieved Critical View of Safety (CVS), while Group B (n=383) had a difficult field with higher complication risk.5

Key Findings:5

  1. Haemostasis was achieved, the liver bed packed with surgical fibrillar absorbable haemostat (ORC), and a drain placed when necessary.
  2. No postoperative bile leaks, re-explorations, re-hospitalization, biliary system procedure (MRCP/ERCP), or conversions to open surgery were reported
  3. Even in technically difficult cases, safe haemostasis was achieved

These findings demonstrate that ORC significantly contributes to bleeding control and reduces surgical risk.

Conclusion

Surgi-ORC® offers an effective adjunct by promoting rapid, localized haemostasis and reducing the risk of surgical complications and conversion to open surgery. By improving bleeding control, maintaining clear surgical fields, and supporting safer dissection. Surgi-ORC® contributes to enhanced surgical confidence and better patient outcomes in both routine and high-risk laparoscopic cholecystectomy cases.

Comments

Post a Comment

Popular posts from this blog

Revolutionizing Surgical Hemostasis: Introducing Surgi-ORC® Powder (Absorbable Hemostatic Powder)

Image
  In modern surgery, efficiently managing perioperative bleeding is crucial. Uncontrolled surgical bleeding poses significant risks to patient health and leads to substantial clinical and healthcare resource burdens. This challenge is particularly pronounced with an aging population and the rising prevalence of comorbidities and anticoagulant use. To address these issues, topical hemostatic agents have emerged as vital tools, promoting hemostasis where conventional methods fall short. These agents vary widely in properties, mode of action, ease of use, safety, and cost. Their selection often depends on the specific surgical scenario, bleeding situation, and patient’s health status. Exploring Topical Hemostatic Agents The current array of topical hemostatic agents comprises several types, each designed to meet different needs in the surgical setting: Mechanical Agents:  These are regarded as the simplest, safest, and most cost-effective. They offer a structural framework for he...
Read more

Comprehensive Health Check-Up: A Commitment to Employee Well-Being

Image
Introduction In today’s fast-paced work environment, the health of employees can often take a back seat to the pressures of meeting deadlines and maintaining productivity. However, maintaining a healthy workforce is crucial for fostering a positive work environment and ensuring long-term organizational success. Regular health check-ups at the office serve as an effective means to address this challenge, ensuring that employees have access to necessary health assessments without the need to disrupt their work routines. The positive impact of these initiatives not only improves employee well-being but also reinforces the company’s commitment to a healthier workforce. This blog will delve into why these check-ups are crucial and provide insights into how they can be effectively implemented in the workplace. Aegis Lifesciences Leads the Way in Workplace Wellness It’s often said that prevention is better than cure, a principle that Aegis Lifesciences upholds in its commitment to employee he...
Read more

Role of Surgi-ORC® Fibril and SURGISPON® in Posterior Fossa Tumor Resections

Image
  In posterior fossa tumor resections, Surgi-ORC® Fibril and SURGISPON® play crucial roles in facilitating a successful surgery and promoting optimal patient outcomes. Here's how they contribute to the surgical process: Hemostasis : One of the primary roles of both Surgi-ORC® Fibril and SURGISPON® is to assist in achieving hemostasis, which is the control of bleeding during surgery. Posterior fossa tumor resections can involve intricate procedures near sensitive structures such as the brainstem and cranial nerves, where bleeding must be carefully managed to maintain a clear surgical field and prevent complications. Surgi-ORC® Fibril and SURGISPON® are applied to bleeding surfaces to promote clot formation and minimize bleeding, thus enhancing visibility and surgical precision. Tissue Protection : During posterior fossa tumor resections, it's essential to protect delicate neural tissues from damage during surgical manipulation. Surgi-ORC® Fibril and SURGISPON® act as physical ba...
Read more